Recombinant Human GGT1 Protein，His

GGT1, or gamma-glutamyltransferase 1, is an enzyme pivotal in the metabolism of glutathione and the modulation of cellular oxidative stress. It plays a significant role in catalyzing the transfer of gamma-glutamyl groups from glutathione to various amino acids and peptides, thereby participating in pivotal cellular processes. Research indicates that GGT1 is implicated in a variety of physiological and pathological states, including tumor progression, liver diseases, and neurodegenerative disorders, where its expression levels often correlate with disease severity or patient prognosis. The interest in recombinant GGT1 protein arises from its potential as a therapeutic target and a biomarker for disease diagnosis. Understanding its structure and function through recombinant expression systems allows for the exploration of its enzymatic mechanisms and interactions. Furthermore, the availability of purified GGT1 protein provides a powerful tool for drug development, elucidation of metabolic pathways, and investigation of its role in oxidative stress responses. Studies in this domain aim to provide insights into how GGT1 modulation may contribute to therapeutic strategies in cancer treatment and oxidative stress management, highlighting its significance in both basic and applied biomedical research.